Lam JT - Search Results

1

Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids.

Lam JT, Bauerschmitz GJ, Kanerva A, Barker SD, Straughn JM, Wang M, Barnes MN, Blackwell JL, Siegal GP, Alvarez RD, Curiel DT, Hemminki A. Lam JT, et al. Cancer Gene Ther. 2003 May;10(5):377-87. doi: 10.1038/sj.cgt.7700578. Cancer Gene Ther. 2003. PMID: 12719707

2

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma.

Kanerva A, Bauerschmitz GJ, Yamamoto M, Lam JT, Alvarez RD, Siegal GP, Curiel DT, Hemminki A. Kanerva A, et al. Among authors: lam jt. Gene Ther. 2004 Mar;11(6):552-9. doi: 10.1038/sj.gt.3302181. Gene Ther. 2004. PMID: 14999227

3

Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.

Wu H, Han T, Lam JT, Leath CA, Dmitriev I, Kashentseva E, Barnes MN, Alvarez RD, Curiel DT. Wu H, et al. Among authors: lam jt. Gene Ther. 2004 May;11(10):874-8. doi: 10.1038/sj.gt.3302249. Gene Ther. 2004. PMID: 14999229

4

A three-dimensional assay for measurement of viral-induced oncolysis.

Lam JT, Hemminki A, Kanerva A, Lee KB, Blackwell JL, Desmond R, Siegal GP, Curiel DT. Lam JT, et al. Cancer Gene Ther. 2007 Apr;14(4):421-30. doi: 10.1038/sj.cgt.7701028. Epub 2007 Jan 19. Cancer Gene Ther. 2007. PMID: 17235353 Free PMC article.

5

Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.

Kanerva A, Mikheeva GV, Krasnykh V, Coolidge CJ, Lam JT, Mahasreshti PJ, Barker SD, Straughn M, Barnes MN, Alvarez RD, Hemminki A, Curiel DT. Kanerva A, et al. Among authors: lam jt. Clin Cancer Res. 2002 Jan;8(1):275-80. Clin Cancer Res. 2002. PMID: 11801569

6

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, Dmitriev I, Krasnykh V, Mikheeva GV, Barnes MN, Alvarez RD, Dall P, Alemany R, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Among authors: lam jt. Cancer Res. 2002 Mar 1;62(5):1266-70. Cancer Res. 2002. PMID: 11888888

7

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.

Kanerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A. Kanerva A, et al. Among authors: lam jt. Mol Ther. 2002 Jun;5(6):695-704. doi: 10.1006/mthe.2002.0599. Mol Ther. 2002. PMID: 12027553 Free article.

8

Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication.

Kawakami Y, Li H, Lam JT, Krasnykh V, Curiel DT, Blackwell JL. Kawakami Y, et al. Among authors: lam jt. Cancer Res. 2003 Mar 15;63(6):1262-9. Cancer Res. 2003. PMID: 12649186

9

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus.

Kanerva A, Zinn KR, Chaudhuri TR, Lam JT, Suzuki K, Uil TG, Hakkarainen T, Bauerschmitz GJ, Wang M, Liu B, Cao Z, Alvarez RD, Curiel DT, Hemminki A. Kanerva A, et al. Among authors: lam jt. Mol Ther. 2003 Sep;8(3):449-58. doi: 10.1016/s1525-0016(03)00200-4. Mol Ther. 2003. PMID: 12946318 Free article.

10

Transcriptional blocks limit adenoviral replication in primary ovarian tumor.

Preuss MA, Lam JT, Wang M, Leath CA 3rd, Kataram M, Mahasreshti PJ, Alvarez RD, Curiel DT. Preuss MA, et al. Among authors: lam jt. Clin Cancer Res. 2004 May 1;10(9):3189-94. doi: 10.1158/1078-0432.ccr-03-0802. Clin Cancer Res. 2004. PMID: 15131060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters